BusinessRitter Pharmaceuticals Announces 1-for-10 Reverse Stock SplitBy Nasdaq OMXMar 22, 2018, 3:35 PM UTC
BusinessRitter Pharmaceuticals, Inc.’s Board Approves 1-for-10 Reverse Stock SplitBy Nasdaq OMXMar 1, 2018, 9:20 PM UTC
BusinessRitter Pharmaceuticals Presents at the 10th Annual LD Micro Conference on December 5, 2017By Nasdaq OMXNov 29, 2017, 2:30 PM UTC
BusinessRitter Pharmaceuticals Presents at the 5th Microbiome R&D Business Collaboration Forum / 2nd Annual Probiotic CongressBy Nasdaq OMXNov 2, 2017, 8:51 PM UTC
BusinessRitter Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business UpdateBy Nasdaq OMXOct 31, 2017, 10:45 AM UTC
BusinessRitter Pharmaceuticals, Inc. Raises $23 Million to Fund Initiation of Its Phase 3 Clinical Program in Lactose IntoleranceBy Nasdaq OMXOct 3, 2017, 4:00 PM UTC
